Przedstawiamy wybór publikacji naukowych związanych z immunoterapią IOZK. Możesz użyć filtrów, aby dokonać wyboru według typów nowotworów i metod lub wprowadzić wyszukiwane hasła.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002001-09-01 / Eur. J. Cancer 2001 Sep;37(13):1599-608https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2001-09-01 / Eur. J. Cancer 2001 Sep;37(13):1599-6082001-09-01 00:00:002001-09-01 00:00:00Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002001-09-01 / Cancer Immunol. Immunother. 2001 Sep;50(7):337-44https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2001-09-01 / Cancer Immunol. Immunother. 2001 Sep;50(7):337-442001-09-01 00:00:002019-02-15 08:47:02Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002001-09-01 / Cancer Res. 2001 Sep;61(17):6445-50https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2001-09-01 / Cancer Res. 2001 Sep;61(17):6445-502001-09-01 00:00:002019-02-15 09:23:53Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002001-09-01 / Int J Hyperthermia 2001 Sep-Oct;17(5):428-38https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2001-09-01 / Int J Hyperthermia 2001 Sep-Oct;17(5):428-382001-09-01 00:00:002001-09-01 00:00:00Effect of whole body hyperthermia on radiation therapy of transplanted fibrosarcoma in Swiss mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002001-07-01 / Eur. J. Cancer 2001 Jul;37(11):1429-34https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2001-07-01 / Eur. J. Cancer 2001 Jul;37(11):1429-342001-07-01 00:00:002019-02-15 08:39:25Enhancement of the therapeutic outcome of radio-immunotherapy by combination with whole-body mild hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002001-06-01 / Lancet Oncol. 2001 Jun;2(6):343-53https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2001-06-01 / Lancet Oncol. 2001 Jun;2(6):343-532001-06-01 00:00:002019-02-15 08:44:53The use of dendritic cells in cancer therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002001-05-01 / Eur. J. Immunol. 2001 May;31(5):1602-9https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2001-05-01 / Eur. J. Immunol. 2001 May;31(5):1602-92001-05-01 00:00:002019-02-15 09:18:06The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002001-05-01 / Int. J. Oncol. 2001 May;18(5):945-52https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2001-05-01 / Int. J. Oncol. 2001 May;18(5):945-522001-05-01 00:00:002020-06-23 09:45:33Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002001-05-01 / J. Neurooncol. 2001 May;53(1):39-46https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2001-05-01 / J. Neurooncol. 2001 May;53(1):39-462001-05-01 00:00:002001-05-01 00:00:00Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002001-03-01 / J. Gastroenterol. Hepatol. 2001 Mar;16(3):309-16https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2001-03-01 / J. Gastroenterol. Hepatol. 2001 Mar;16(3):309-162001-03-01 00:00:002019-02-15 08:37:58Generation of hepatitis C virus-specific cytotoxic T lymphocytes from healthy individuals with peptide-pulsed dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002001-02-01 / Onkologie 2001 Feb;24(1):55-8https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2001-02-01 / Onkologie 2001 Feb;24(1):55-82001-02-01 00:00:002019-02-15 09:17:56Posttreatment histology and microcirculation status of osteogenic sarcoma after a neoadjuvant chemo- and radiotherapy in combination with local electromagnetic hyperthermia
Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study
Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells
Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines
Effect of whole body hyperthermia on radiation therapy of transplanted fibrosarcoma in Swiss mice
Enhancement of the therapeutic outcome of radio-immunotherapy by combination with whole-body mild hyperthermia
Immunotherapy of multiple myeloma
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
[Addition of hyperthermia. Heat potentiates cancer therapy]
The use of dendritic cells in cancer therapy
The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors
Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects
Localised spontaneous regression in mesothelioma — possible immunological mechanism
Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme
Dendritic cells for specific cancer immunotherapy
Generation of hepatitis C virus-specific cytotoxic T lymphocytes from healthy individuals with peptide-pulsed dendritic cells
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
Posttreatment histology and microcirculation status of osteogenic sarcoma after a neoadjuvant chemo- and radiotherapy in combination with local electromagnetic hyperthermia
Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration
Dendritic cells and chronic hepatitis virus carriers
Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein